Cardiology, University of Helsinki, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
Department of Cardiology, Acute and Intensive Cardiovascular Care Unit, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-Sant Pau, Universitat Autònoma de Barcelona, CIBER-CV, Barcelona, Spain.
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):1-8. doi: 10.1002/ccd.27716. Epub 2018 Sep 12.
The aim was to assess the extent of coronary artery disease and revascularization using baseline SYNTAX Score (bSS) and residual SYNTAX Score (rSS) in patients with cardiogenic shock (CS) secondary to ST-segment elevation myocardial infarction (STEMI). The prognostic impact of SYNTAX Score (SS) was evaluated and assessed for additive value over clinical risk scores.
bSS and rSS have been proven to be useful in risk stratification in stable coronary artery disease as well as in acute coronary syndromes, but they have not been studied in STEMI related CS.
Patients from a multinational prospective study of CS were analyzed. The study population was divided into tertiles according to bSS. The Cox regression and receiver operating characteristic (ROC) curves were used to assess the predictive power of SS.
Of the 61 studied patients, 85% were male and the mean age was 67 years. Median bSS was 22 (15-32) and rSS 7 (0-13). Ninety-day mortality was 43%. bSS had negative prognostic value in multivariable analysis (HR 1.06, 95% CI 1.01-1.10). However, additive value over clinical risk scores was limited. rSS was not associated with mortality, whereas post-percutaneous coronary intervention (PCI) TIMI flow 3 of infarct-related artery (IRA) predicted better survival.
In STEMI related CS, the added value of bSS and rSS over clinical assessment and risk scores is limited. Our results suggest that while immediate PCI in order to restore blood flow to the IRA is essential, deferring the treatment of residual lesions does not seem to be associated with worse prognosis.
评估因 ST 段抬高型心肌梗死(STEMI)导致的心源性休克(CS)患者的冠状动脉疾病和血运重建程度,使用基线 SYNTAX 评分(bSS)和残余 SYNTAX 评分(rSS)。评估 SYNTAX 评分(SS)的预后影响,并评估其相对于临床风险评分的附加价值。
bSS 和 rSS 已被证明在稳定型冠状动脉疾病以及急性冠状动脉综合征的风险分层中有用,但尚未在 STEMI 相关 CS 中进行研究。
对一项多中心前瞻性 CS 研究的患者进行分析。根据 bSS 将研究人群分为三分位组。使用 Cox 回归和接受者操作特征(ROC)曲线评估 SS 的预测能力。
在 61 例研究患者中,85%为男性,平均年龄为 67 岁。中位数 bSS 为 22(15-32),rSS 为 7(0-13)。90 天死亡率为 43%。多变量分析显示 bSS 具有负预后价值(HR 1.06,95%CI 1.01-1.10)。然而,相对于临床风险评分的附加价值有限。rSS 与死亡率无关,而经皮冠状动脉介入治疗(PCI)后梗死相关动脉(IRA)的 TIMI 血流 3 与更好的生存相关。
在 STEMI 相关 CS 中,bSS 和 rSS 相对于临床评估和风险评分的附加价值有限。我们的结果表明,尽管立即进行 PCI 以恢复 IRA 的血流至关重要,但延迟治疗残余病变似乎与预后恶化无关。